French recommendations for assessing and managing the risk of cancer before initiating targeted therapies for chronic rheumatic inflammatory diseases.

Avouac J, Fogel O, Beydon M, Frémont GM, Birsen G, Carcopino X, Immediato Daien C, Desouches S, Domblides C, Gaujoux-Viala C, Gottenberg JE, Letarouilly JG, Nocturne G, Prati C, Salmon JH, Sellam J, Truchetet ME, Wislez M, Pico-Philippe I, Vacher D, Seror R, Molto A; French Society of Rheumatology.